Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer
Debashis Sahoo, Wei Wei, Heidi Auman, Antonio Hurtado-Coll, Peter R. Carroll, Ladan Fazli, Martin E. Gleave, Daniel W. Lin, Peter S. Nelson, Jeff Simko, Ian M. Thompson, Robin J. Leach, Dean A. Troyer, Lawrence D. True, Jesse K. McKenney, Ziding Feng, James D. Brooks
Dive into the research topics of 'Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer'. Together they form a unique fingerprint.